614 research outputs found
Recommended from our members
The View of Russian Students on Whether Psychology is a Science
The Psychology as Science Scale (Friedrich, 1996) was administered to 525 psychology students from nine Russian universities to assess their beliefs about the nature of the discipline. About half of students (49.6%) generally agreed that psychology may be called a scientific discipline. Specifically, 71. 5% of the students agreed that psychology is a natural science, similar to biology, chemistry, and physics, 39. 9% of students agreed that psychological research is important and training in psychological methodology is necessary, and 43.1% of students agreed that human behavior is highly predictable. Students who took three methodology courses shared significantly stronger beliefs in the need for psychological research and the importance of training in methodology compared to students who did not take any methodology courses. Furthermore, students with a specialist degree had significantly stronger beliefs that psychology is a science compared to students who have just finished school. In terms of the effect of studentsβ career aspirations, students who wanted to be academic psychologists and clinicians had significantly stronger beliefs that psychology is a science compared to students who did not have clarity about their future careers. Regardless of the study limitations, these findings have potential implications for Russian psychology instructors
Π‘ΠΈΠ½ΡΠ΅Π· ΡΠ° Π΄ΡΡΡΠ΅ΡΠΈΡΠ½Π° Π΄ΡΡ 8-Π°ΠΌΡΠ½ΠΎΠ·Π°ΠΌΡΡΠ΅Π½ΠΈΡ 7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ
It has been found that natural xanthines, as well as their synthetic analogs, possess the diuretic effect. Analysis of the literature proves that there is a great opportunity of applying synthetic derivatives of N-methylated xanthines as potential diuretics.Aim. To develop preparative methods of the synthesis of 8-aminosubstituted of 7-(2-hydroxy-3-p-metoxyphenoxypropyl-1)-3-methylxanthine and study their physical, chemical and biological properties. Results. The synthesis of a series of 8-aminosubstituted of 7-(2-hydroxy-3-p-metoxyphenoxypropyl-1)-3-methylxanthine was carried out. According to the results of the biological testing the compounds synthesized belong to the toxicity of class IV. 7-(2-Hydroxy-3-p-methoxyphenoxypropyl-1)-8-(furyl-2-methylamino)-3-methylxanthine xanthine shows the highest diuretic activity, and hence, requires a more in-depth study since it is twice more active than hydrochlorothiazide. It should be emphasized that all compounds synthesized exhibit a marked diuretic effect. Experimental part. 8-Bromo-7-(2-hydroxy-3-p-methoxyphenoxypropyl-1)-3-methylxanthine was obtained by heating 8-bromo-3-methylxanthine with p-methoxyphenoxymethyloxirane in butanol-1 and in the presence of N,N-dimethylbenzylamine. 8-Aminosubstitutied of 7-(2-hydroxy-3-p-metoxyphenoxypropyl-1)-3-methylxanthine was obtained by boiling of bromoalcohol with the primary and secondary amines. The structure of the compounds synthesized was unambiguously confirmed by NMR-spectroscopy. The acute toxicity of the compounds obtained was studied by Kerber method. The study of the diuretic activity of the compounds was carried out using Ye. Berkhin method. Hydrochlorothiazide was used as a reference substance. Conclusions. Simple methods for the synthesis of 8-amino-7- (2-hydroxy-3-p-methoxyphenoxypropyl-1)-3-methylxanthines have been developed. The structure of the compounds synthesized has been confirmed by the method of NMR 1H-spectroscopy. The acute toxicity and the diuretic activity of the compounds obtained have been studied.ΠΠ·Π²Π΅ΡΡΠ½ΠΎ, ΡΡΠΎ ΠΊΠ°ΠΊ ΠΏΡΠΈΡΠΎΠ΄Π½ΡΠ΅ ΠΊΡΠ°Π½ΡΠΈΠ½Ρ, ΡΠ°ΠΊ ΠΈ ΠΈΡ
ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½Π°Π»ΠΎΠ³ΠΈ ΠΎΠ±Π»Π°Π΄Π°ΡΡ Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ. ΠΠ½Π°Π»ΠΈΠ· Π΄Π°Π½Π½ΡΡ
Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ
N-ΠΌΠ΅ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΡΠ°Π½ΡΠΈΠ½ΠΎΠ² Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΡΡ
Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΠ΅Π΄ΡΡΠ². Π¦Π΅Π»Ρ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ β ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΠΈΠ½ΡΠ΅Π·Π° 8-Π°ΠΌΠΈΠ½ΠΎΠ·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ
7-(2-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΠΈΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Π° ΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΈΡ
ΡΠΈΠ·ΠΈΠΊΠΎ-Ρ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ²ΠΎΠΉΡΡΠ². Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΈΡ
ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. Π‘ΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½ ΡΡΠ΄ 8-Π°ΠΌΠΈΠ½ΠΎΠ·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ
7-(2-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΠΈΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Π°. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΠΏΡΡΠ°Π½ΠΈΠΉ ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ IV ΠΊΠ»Π°ΡΡΡ ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΠΈ. 7-(2-ΠΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΠΈΠ»-1)-8-(ΡΡΡΠΈΠ»-2-ΠΌΠ΅ΡΠΈΠ»Π°ΠΌΠΈΠ½ΠΎ)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½ ΠΈΠΌΠ΅Π΅Ρ Π½Π°ΠΈΠ±ΠΎΠ»ΡΡΡΡ Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, Π° ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ Π΄ΠΎΡΠΊΠΎΠ½Π°Π»ΡΠ½ΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅, ΠΏΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΠΎΠ½ Π±ΠΎΠ»Π΅Π΅ ΡΠ΅ΠΌ Π² 2 ΡΠ°Π·Π° Π°ΠΊΡΠΈΠ²Π½Π΅Π΅Β Π³ΠΈΠ΄ΡΠΎΡ
Π»ΠΎΡΡΠΈΠ°Π·ΠΈΠ΄Π°. ΠΠ΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΠΎΠ΄ΡΠ΅ΡΠΊΠ½ΡΡΡ, ΡΡΠΎ Π²ΡΠ΅ ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠ΅ Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅. ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½Π°Ρ ΡΠ°ΡΡΡ. 8-ΠΡΠΎΠΌ-7-(2-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΒΠΏΡΠΎΠΏΠΈΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½ ΠΏΠΎΠ»ΡΡΠ΅Π½ Π½Π°Π³ΡΠ΅Π²Π°Π½ΠΈΠ΅ΠΌ 8-Π±ΡΠΎΠΌ-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Π° Ρ ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΌΠ΅ΡΠΈΠ»ΠΎΠΊΡΠΈΡΠ°Π½ΠΎΠΌ Π² Π±ΡΡΠ°Π½ΠΎΠ»Π΅-1 Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ N,N-Π΄ΠΈΠΌΠ΅ΡΠΈΠ»Π±Π΅Π½Π·ΠΈΠ»Π°ΠΌΠΈΠ½Π°. 8-ΠΠΌΠΈΠ½ΠΎΠ·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ 7-(2-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΒΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΠΈΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Π° ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΏΡΡΠ΅ΠΌ ΠΊΠΈΠΏΡΡΠ΅Π½ΠΈΡ Π±ΡΠΎΠΌΠΎΡΠΏΠΈΡΡΠ° Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΠΌΠΈ ΠΈ Π²ΡΠΎΡΠΈΡΠ½ΡΠΌΠΈ Π°ΠΌΠΈΠ½Π°ΠΌΠΈ. Π‘ΡΡΡΠΊΡΡΡΠ° ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΠΎΠ΄Π½ΠΎΠ·Π½Π°ΡΠ½ΠΎ Π΄ΠΎΠΊΠ°Π·Π°Π½Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ. ΠΡΡΡΠ°Ρ ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡ ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΠΈΠ·ΡΡΠ°Π»Π°ΡΡ ΠΏΠΎ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΠ΅ΡΠ±Π΅ΡΠ°. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΠΎ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΠ΅ΡΡ
ΠΈΠ½Π° Π. Π. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΡΡΠ°Π»ΠΎΠ½Π° ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ Π³ΠΈΠ΄ΡΠΎΡ
Π»ΠΎΡΡΠΈΠ°Π·ΠΈΠ΄. ΠΡΠ²ΠΎΠ΄Ρ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Ρ ΠΏΡΠΎΡΡΡΠ΅ Π² Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΡΠΈΠ½ΡΠ΅Π·Π° 8-Π°ΠΌΠΈΠ½ΠΎΠ·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ
7-(2-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΠΈΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Π°. Π‘ΡΡΡΠΊΡΡΡΠ° ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ Π΄ΠΎΠΊΠ°Π·Π°Π½Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ. ΠΠ·ΡΡΠ΅Π½Π° ΠΎΡΡΡΠ°Ρ ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡ ΠΈ Π΄ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
Π²Π΅ΡΠ΅ΡΡΠ².ΠΡΠ΄ΠΎΠΌΠΎ, ΡΠΎ ΡΠΊ ΠΏΡΠΈΡΠΎΠ΄Π½Ρ ΠΊΡΠ°Π½ΡΠΈΠ½ΠΈ, ΡΠ°ΠΊ Ρ ΡΡ
ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ½Ρ Π°Π½Π°Π»ΠΎΠ³ΠΈ Π²ΠΈΡΠ²Π»ΡΡΡΡ Π΄ΡΡΡΠ΅ΡΠΈΡΠ½Ρ Π΄ΡΡ. ΠΠ½Π°Π»ΡΠ· Π΄Π°Π½ΠΈΡ
Π»ΡΡΠ΅ΡΠ°ΡΡΡΠΈ ΡΠ²ΡΠ΄ΡΠΈΡΡ ΠΏΡΠΎ Π·Π½Π°ΡΠ½Ρ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ½ΠΈΡ
ΠΏΠΎΡ
ΡΠ΄Π½ΠΈΡ
N-ΠΌΠ΅ΡΠΈΠ»ΡΠΎΠ²Π°Π½ΠΈΡ
ΠΊΡΠ°Π½ΡΠΈΠ½ΡΠ² Π² ΡΠΊΠΎΡΡΡ ΠΏΠΎΡΠ΅Π½ΡΡΠΉΠ½ΠΈΡ
Π΄ΡΡΡΠ΅ΡΠΈΡΠ½ΠΈΡ
Π·Π°ΡΠΎΠ±ΡΠ². ΠΠ΅ΡΠΎΡ Π΄Π°Π½ΠΎΡ ΡΠΎΠ±ΠΎΡΠΈ Ρ ΡΠΎΠ·ΡΠΎΠ±ΠΊΠ° ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ² ΡΠΈΠ½ΡΠ΅Π·Ρ 8-Π°ΠΌΡΠ½ΠΎΠ·Π°ΠΌΡΡΠ΅Π½ΠΈΡ
7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ ΡΠ° Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ ΡΡ
ΡΡΠ·ΠΈΠΊΠΎ-Ρ
ΡΠΌΡΡΠ½ΠΈΡ
ΡΠ° Π±ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ
Π²Π»Π°ΡΡΠΈΠ²ΠΎΡΡΠ΅ΠΉ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ ΡΠ° ΡΡ
ΠΎΠ±Π³ΠΎΠ²ΠΎΡΠ΅Π½Π½Ρ. ΠΡΠ² ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½ΠΈΠΉ ΡΡΠ΄ 8-Π°ΠΌΡΠ½ΠΎΠ·Π°ΠΌΡΡΠ΅Π½ΠΈΡ
7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ. ΠΠ° ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ Π±ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ
Π²ΠΈΠΏΡΠΎΠ±ΡΠ²Π°Π½Ρ ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½Ρ ΡΠΏΠΎΠ»ΡΠΊΠΈ Π²ΡΠ΄Π½ΠΎΡΡΡΡΡΡ Π΄ΠΎ IV ΠΊΠ»Π°ΡΡ ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡ. 7-(2-ΠΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-8-(ΡΡΡΠΈΠ»-2-ΠΌΠ΅ΡΠΈΠ»Π°ΠΌΡΠ½ΠΎ)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½ Π²ΠΈΡΠ²Π»ΡΡ Π½Π°ΠΉΠ²ΠΈΡΡ Π΄ΡΡΡΠ΅ΡΠΈΡΠ½Ρ Π°ΠΊΡΠΈΠ²Π½ΡΡΡΡ, Π° ΠΎΡΠΆΠ΅ ΠΏΠΎΡΡΠ΅Π±ΡΡ Π±ΡΠ»ΡΡ Π΄ΠΎΡΠΊΠΎΠ½Π°Π»ΠΎΠ³ΠΎ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ, ΠΎΡΠΊΡΠ»ΡΠΊΠΈ Π²ΡΠ½ Π±ΡΠ»ΡΡ Π½ΡΠΆ Ρ 2 ΡΠ°Π·ΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡΠΈΠΉ Π·Π° Π³ΡΠ΄ΡΠΎΡ
Π»ΠΎΡΡΡΠ°Π·ΠΈΠ΄. ΠΠ΅ΠΎΠ±Ρ
ΡΠ΄Π½ΠΎ ΠΏΡΠ΄ΠΊΡΠ΅ΡΠ»ΠΈΡΠΈ, ΡΠΎ Π²ΡΡ ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½Ρ ΡΠΏΠΎΠ»ΡΠΊΠΈ Π²ΠΈΡΠ²Π»ΡΡΡΡ Π²ΠΈΡΠ°Π·Π½Ρ Π΄ΡΡΡΠ΅ΡΠΈΡΠ½Ρ Π΄ΡΡ.ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½Π° ΡΠ°ΡΡΠΈΠ½Π°. 8-ΠΡΠΎΠΌΠΎ-7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½ ΠΎΡΡΠΈΠΌΠ°Π»ΠΈ Π½Π°Π³ΡΡΠ²Π°Π½Π½ΡΠΌ 8-Π±ΡΠΎΠΌΠΎ-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ Π· ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΌΠ΅ΡΠΈΠ»ΠΎΠΊΡΠΈΡΠ°Π½ΠΎΠΌ Ρ Π±ΡΡΠ°Π½ΠΎΠ»Ρ-1 Π² ΠΏΡΠΈΡΡΡΠ½ΠΎΡΡΡ N,N-Π΄ΠΈΠΌΠ΅ΡΠΈΠ»Π±Π΅Π½Π·ΠΈΠ»Π°ΠΌΡΠ½Ρ. 8-ΠΠΌΡΠ½ΠΎΠ·Π°ΠΌΡΡΠ΅Π½Ρ 7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½Ρ ΡΠ»ΡΡ
ΠΎΠΌ ΠΊΠΈΠΏβΡΡΡΠ½Π½Ρ Π±ΡΠΎΠΌΠΎΡΠΏΠΈΡΡΡ Π· ΠΏΠ΅ΡΠ²ΠΈΠ½Π½ΠΈΠΌΠΈ ΡΠ° Π²ΡΠΎΡΠΈΠ½Π½ΠΈΠΌΠΈ Π°ΠΌΡΠ½Π°ΠΌΠΈ. Π‘ΡΡΡΠΊΡΡΡΠ° ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½ΠΈΡ
ΡΠΏΠΎΠ»ΡΠΊ Π±ΡΠ»Π° ΠΎΠ΄Π½ΠΎΠ·Π½Π°ΡΠ½ΠΎ Π΄ΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΡΡ. ΠΠΎΡΡΡΠ° ΡΠΎΠΊΡΠΈΡΠ½ΡΡΡΡ ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½ΠΈΡ
ΡΠΏΠΎΠ»ΡΠΊ Π±ΡΠ»Π° Π²ΠΈΠ²ΡΠ΅Π½Π° Π·Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ΅ΡΠ±Π΅ΡΠ°. ΠΠΈΠ²ΡΠ΅Π½Π½Ρ Π΄ΡΡΡΠ΅ΡΠΈΡΠ½ΠΎΡ Π΄ΡΡ ΠΎΡΡΠΈΠΌΠ°Π½ΠΈΡ
ΡΠΏΠΎΠ»ΡΠΊ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π·Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ΅ΡΡ
ΡΠ½Π° Π. Π. Π ΡΠΊΠΎΡΡΡ Π΅ΡΠ°Π»ΠΎΠ½Ρ ΠΏΠΎΡΡΠ²Π½ΡΠ½Π½Ρ Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΠ²Π°Π»ΠΈ Π³ΡΠ΄ΡΠΎΡ
Π»ΠΎΡΡΡΠ°Π·ΠΈΠ΄. ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. ΠΡΠ»ΠΈ ΡΠΎΠ·ΡΠΎΠ±Π»Π΅Π½Ρ ΠΏΡΠΎΡΡΡ Ρ Π²ΠΈΠΊΠΎΠ½Π°Π½Π½Ρ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΡΠΈΠ½ΡΠ΅Π·Ρ 8-Π°ΠΌΡΠ½ΠΎΠ·Π°ΠΌΡΡΠ΅Π½ΠΈΡ
7-(2-Π³ΡΠ΄ΡΠΎΠΊΡΠΈ-3-ΠΏ-ΠΌΠ΅ΡΠΎΠΊΡΠΈΡΠ΅Π½ΠΎΠΊΡΠΈΠΏΡΠΎΠΏΡΠ»-1)-3-ΠΌΠ΅ΡΠΈΠ»ΠΊΡΠ°Π½ΡΠΈΠ½Ρ. Π‘ΡΡΡΠΊΡΡΡΠ° ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½ΠΈΡ
ΡΠΏΠΎΠ»ΡΠΊ Π±ΡΠ»Π° Π΄ΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ -ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΡΡ. ΠΠΈΠ²ΡΠ΅Π½Π° Π³ΠΎΡΡΡΠ° ΡΠΎΠΊΡΠΈΡΠ½ΡΡΡΡ ΡΠ° Π΄ΡΡΡΠ΅ΡΠΈΡΠ½Π° Π°ΠΊΡΠΈΠ²Π½ΡΡΡΡ ΠΎΡΡΠΈΠΌΠ°Π½ΠΈΡ
ΡΠ΅ΡΠΎΠ²ΠΈΠ½
PREVENTION OF ONCOLOGICAL DISEASES AS THE BASIS OF INTERACTION OF ONCOLOGICAL SERVICE WITH PRIMARY LINK OF HEALTH CARE
Malignant neoplasms (MN) are the second cause of death for the population of Russia, resulted in 15.5% of all deaths in 2015. Their share in the structure of the male population mortality rate was 16.4%, female β 14.4%. Among both sexes, deaths of working age, the proportion of deaths from MN was 16.0%, among women of reproductive age β 16.3%. More than half of the working age population of deaths in Russia falls on the disease from the group of preventable death, and a third β to preventable causes, depending on the primary and secondary prevention, quality of care, along with a high prevalence of behavioral risk factors (RF), demographic characteristics, marked medical and social reasons for the high mortality rate of the MN: late uptake of the population for health care, lack of alertness in oncology healthcare professionals, patients defects in routing.The leading factor in increasing life expectancy is prevention. Today, prevention is regarded as active method of strengthening and preservation of health, and the currently existing approaches in promoting healthy life mostly only directed at the prevention of behavioral risk factors: tobacco use, poor diet, physical inactivity and harmful use of alcohol. Experts estimate the impact on them will prevent, at least 40% of the cases of MN.In Russia we have a 3-step system of health care. In general preventive health orientation is implemented on the 1st level: in the provision of primary health care. In this regard, particular attention should be paid to the implementation of measures for specific clinical examination of the adult population, which plays an important role in the early detection of both the disease and the risk factors for their development. Properly organized conduct of the clinical examination can provide a substantial, up to 30%, the contribution to the reduction of total mortality, including mortality from MN. The necessity of increasing the role of the oncology service in the organizational and methodological support of the preventive measures implemented by primary health care is performed
Coupled phase transformations and plastic flows under torsion at high pressure in rotational diamond anvil cell: Effect of contact sliding
A three-dimensional large-sliding contact model coupled with strain-induced phase transformations (PTs) and plastic flow in a disk-like sample under torsion at high pressure in rotational diamond anvil cell (RDAC) is formulated and studied. Coulomb and plastic friction are combined and take into account variable parameters due to PT. Results are obtained for weaker, equal-strength, and stronger high pressure phases, and for three values of the kinetic coefficient in a strain-controlled kinetic equation and friction coefficient. All drawbacks typical of problem with cohesion are overcome, including eliminating mesh-dependent shear band and artificial plastic zones. Contact sliding intensifies radial plastic flow, which leads to larger reduction in sample thickness. Larger plastic strain and increased pressure in the central region lead to intensification of PT. However, the effect of the reduction in the friction coefficient on PT kinetics is nonmonotonous. Sliding increases away from the center and with growing rotation and is weakly dependent on the kinetic coefficient. Also, cyclic back and forth torsion is studied and compared to unidirectional torsion. Multiple experimental phenomena, e.g., pressure self-multiplication effect, steps (plateaus) at pressure distribution, flow to the center of a sample, and oscillatory pressure distribution for weaker high-pressure phase, are reproduced and interpreted. Reverse PT in high pressure phase that flowed to the low pressure region is revealed. Possible misinterpretation of experimental PT pressure is found. Obtained results represent essential progress toward understanding of strain-induced PTs under compression and shear in RDAC and may be used for designing experiments for synthesis of new high pressure phases and reduction in PT pressure for known phases, as well as for determination of PT kinetics from experiments
Stability of the Industrial Reference Standard of Tuberculosis Vaccine (BCG)
The industrial reference standard of tuberculosis (BCG) vaccine (IRS), certified and registered by the Federal State Budgetary Institution βScientific Centre for Expert Evaluation of Medicinal Productsβ of the Ministry of Health of the Russian Federation (OSO 42-28-420), is used as a reference product in quality control of tuberculosis vaccines BCG and BCG-M. The IRS is a useful means of quality control of these products, as the stability of its proper ties helps to minimise errors during quality evaluation. The shelf life of the BCG vaccine IRS is not more than 2 years if stored at 2β8 Β°C. It is likely that a vaccine batch could be used as the IRS for a longer period of time. The literature data suggest that the shelf life of a BCG vaccine can be prolonged if it is stored at low temperatures. However, due to significant phenotypic and genotypic differences between BCG sub-strains, the extrapolation of these data to the vaccine produced from the Russian Mycobacterium bovis BCG-I sub-strain requires appropriate testing. The aim of the study was to analyse the possibility of increasing the shelf life of the tuberculosis vaccine IRS by changing the storage temperature. Materials and methods: the effect of low temperatures on the stability of OSO 42-28-420 was studied in commercial batches of tuberculosis vaccine which met all the quality requirements for candidate IRSs. Samples from 6 IRS batches produced from 2014 through 2019 were stored at β(20 Β± 1) Β°Π‘. The stability of their quality characteristics, namely βSpecific activity (viability)β, βTotal bacterial countβ, and βDispersibilityβ, was monitored according to the recommendations of the World Health Organization. The obtained data were evaluated relative to the baseline data obtained during certification of each batch. Results: it was demonstrated that there was more than 95 percent probability that the tested parameters would not differ from the initial data if OSO 42-28-420 samples were stored at a low temperature for 5 years. Conclusions: the results obtained support the prolongation of the OSO 42-28-420 shelf life up to 4 years under the recommended storage conditions at β(20 Β± 1) Β°Π‘
Preoperative management of ophthalmic patients taking oral anticoagulants
Surgical treatment is often accompanied by such complication as bleeding, andΒ ophthalmic surgery is not an exception. The bleeding risk depends on many factors, theΒ most significant are age, arterial hypertension, hepatic and renal impairment, prior stroke or treatment with oral anticoagulants.The aim. To evaluate the structure of patients taking novel oral anticoagulants (NOACs) with anΒ assessment of activated partial thromboplastin time before ophthalmosurgical treatment.Materials and methods. 54Β patients taking oral anticoagulants were included inΒ the study. AΒ retrospective analysis of medical histories of patients who hadΒ surgery for ocular pathology was carried out. The patients were divided into two groups: groupΒ 1 β 28Β patients whose activated partial thromboplastin time (APTT) did notΒ exceed 45Β seconds; groupΒ 2 β 26Β patients with APTT more than 45Β seconds. TheΒ criterion for the numerical expression of APTT is the safety of performing regional anesthesia against the background of taking anticoagulant drugs. Statistical processing wasΒ performed using the MannΒ βΒ Whitney test (pΒ <Β 0.05).Results. A comparative analysis of the results showed that the patients of theΒ groupΒ 2 had higher rates of APTT. At the same time, they were less likely to have acute cerebrovascular accident (11.5Β % compared to 21Β % of patients in the groupΒ 2) and prior acute myocardial infarction (19Β % and 28Β %, respectively). Among all the patients, women and slightly older patients prevailed.Conclusion. Patients with atrial fibrillation make up the majority of patients undergoing ophthalmosurgical treatment and taking NOACs. Surgical treatment method was phacoemulsification with intraocular lens implantation. Studying APTT before the surgery allowed us to identify aΒ category of patients with high APTT, to prescribe the withdrawal of the drug before the surgery inΒ order to create optimal conditions for surgical treatment
Specific Aspects of Tuberculin Products Standardisation
According to the existing international practice, reference materials, which are used to assess specific activity of purified tuberculin products, are meant to be used for several decades and are therefore characterised by high stability. For instance, PPD-S tuberculin produced in the USA in 1944 has been used ever since as the international reference standard of purified tuberculin and is stored as lyophilisate in ampoules (PPDT) containing 5000 IU each. The Russian PPD-L-2 industry reference standard is made from material produced by the Leningrad Research Institute of Vaccines and Sera in 1973. It has been used for many years to control production batches of PPD-L purified tuberculin because of its high stability that is regularly confirmed in large-scale studies using various experimental models in accordance with the requirements of the World Health Organisation. The aim of the study was to evaluate the long-term stability of the substance of industry reference standard of purified tuberculin (PPD-L-2 IRS) by determining its specific activity relative to the international standard of purified tuberculin, and determine the feasibility of using this substance for the preparation of lyophilised reference product samples. Materials and methods: PPD-L-2 IRS specific activity was determined relative to the PPDT international standard in accordance with the procedure specified in the monograph FS.3.3.1.0023.15 of the State Pharmacopoeia of Russian Federation (14 edition) using guinea pigs vaccinated with various BCG substrains or sensitized by virulent mycobacteria (Β«liveΒ» or Β«inactivatedΒ») in accordance with the recommendations of the WHO (WHO TRS 45, 1987). Results: the analysis of the obtained data showed that there were 3β4-fold differences in PPD-L-2 IRS relative potency depending on the BCG substrain used for guinea pigs vaccination (animal sensitization model). This effect of the titration model manifested itself when comparing specific activity of tuberculins obtained by various methods of tuberculoprotein precipitation (PPD-L-2 and PPDT), i.e. different in antigen composition. The specific activity of the previously established dose of PPD-L-2 IRS was shown to be equivalent to the international reference standard in animals sensitized with mycobacteria tuberculosis. Conclusions: the results of PPD-L-2 IRS specific activity assessment obtained in this study are consistent with the data obtained during development and certification of this reference material in the 1980s and confirm the long-term stability of the intermediate powder product of the Russian reference standard of purified tuberculin. At the same time, the production of a freeze-dried form of the IRS, in addition to being economically feasible, would rule out some potential errors that are inevitable during annual preparation and control of the reference standard dilutions, and would make it possible to spare the substance which would improve prospects for the future long-term use of PPD-L as an industry reference standard
ΠΠ°ΠΊΡΠΈΠ½ΠΎΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°
BCG vaccine for tuberculosis was developed nearly 100 years ago and still remains the only medicine for specific immunological prevention of tuberculosis. Despite the fact it has been actively used for a long time in more than 100 countries, the results of vaccination are very contradictory. The protective effect of BCG vaccination is assessed from 0 to 80%, while the efficacy of BCG vaccination in children, especially in infants, is generally recognized. BCG helps to reduce tenfold the number of tuberculous meningitis and disseminated tuberculosis in children. However BCG neither protects the population from mycobacteria infections nor the adults from pulmonary tuberculosis, although it prevents extrapulmonary tuberculosis. For the last 20 years new tuberculosis vaccines have been intensive developed, their efficacy is believed to exceed the efficacy of BCG vaccine, with the minimized adverse reactions. Nevertheless out of more than 200 tuberculosis vaccine candidates only few were allowed for clinical trials. In the upcoming years the humanity can not count upon a medicine that could replace BCG. Therefore the research efforts should be focused on improving BCG vaccine in order to enhance its protective effect and to reduce adverse effects.Π‘ΠΎΠ·Π΄Π°Π½Π½Π°Ρ ΠΏΠΎΡΡΠΈ 100 Π»Π΅Ρ Π½Π°Π·Π°Π΄ Π²Π°ΠΊΡΠΈΠ½Π° ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½Π°Ρ ΠΠ¦Π ΠΎΡΡΠ°Π΅ΡΡΡ Π΄ΠΎ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π΅Π΄ΠΈΠ½ΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ Π΄Π»Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΠΌΠ°ΡΡΠΎΠ²ΠΎΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π² Π±ΠΎΠ»Π΅Π΅ ΡΠ΅ΠΌ Π² 100 ΡΡΡΠ°Π½Π°Ρ
ΠΌΠΈΡΠ°, Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°Ρ
Π²Π°ΠΊΡΠΈΠ½Π°ΡΠΈΠΈ ΠΎΡΡΠ°ΡΡΡΡ ΠΎΡΠ΅Π½Ρ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΠ΅ΡΠΈΠ²ΡΠΌΠΈ. ΠΠ°ΡΠΈΡΠ½ΡΠΉ ΡΡΡΠ΅ΠΊΡ Π²Π°ΠΊΡΠΈΠ½ ΠΠ¦Π ΠΎΡΠ΅Π½ΠΈΠ²Π°ΡΡ ΠΎΡ 0 Π΄ΠΎ 80%, ΠΏΡΠΈ ΡΡΠΎΠΌ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π²Π°ΠΊΡΠΈΠ½Π°ΡΠΈΠΈ ΠΠ¦Π Π΄Π΅ΡΠ΅ΠΉ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ ΡΠ°Π½Π½Π΅Π³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°, ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ·Π½Π°Π½Π½Π°. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΡΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ Π² Π΄Π΅ΡΡΡΠΊΠΈ ΡΠ°Π· ΡΠΈΡΠ»Π° ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΡΡ
ΠΌΠ΅Π½ΠΈΠ½Π³ΠΈΡΠΎΠ² ΠΈ Π΄ΠΈΡΡΠ΅ΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΡΠΌ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π° Ρ Π΄Π΅ΡΠ΅ΠΉ. ΠΠ΄Π½Π°ΠΊΠΎ ΠΠ¦Π Π½Π΅ Π·Π°ΡΠΈΡΠ°Π΅Ρ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΠ΅ ΠΎΡ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΈΠΊΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΡΠΌΠΈ, Π° Π²Π·ΡΠΎΡΠ»ΡΡ
ΠΎΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π° Π»Π΅Π³ΠΊΠΈΡ
, Ρ
ΠΎΡΡ ΠΏΡΠ΅Π΄ΠΎΡΠ²ΡΠ°ΡΠ°Π΅Ρ Π²Π½Π΅Π»Π΅Π³ΠΎΡΠ½ΡΠ΅ ΡΠΎΡΠΌΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°. Π ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ 20 Π»Π΅Ρ Π²Π΅Π΄ΡΡΡΡ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΡΠ΅ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π½ΠΎΠ²ΡΡ
ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΡΡ
Π²Π°ΠΊΡΠΈΠ½, ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΊΠΎΡΠΎΡΡΡ
, ΠΊΠ°ΠΊ ΠΏΠΎΠ»Π°Π³Π°ΡΡ, ΠΏΡΠ΅Π²ΡΡΡΡ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΠ¦Π, ΠΏΡΠΈ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΡΡ
ΠΏΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΡΡ
Π½Π° ΠΈΡ
Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠ΄Π½Π°ΠΊΠΎ ΠΈΠ· 200 Ρ Π»ΠΈΡΠ½ΠΈΠΌ ΠΊΠ°Π½Π΄ΠΈΠ΄Π°ΡΠΎΠ² ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΡΡ
Π²Π°ΠΊΡΠΈΠ½ Π΄ΠΎ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π΄ΠΎΡΠ»ΠΈ Π΅Π΄ΠΈΠ½ΠΈΡΡ. Π Π±Π»ΠΈΠΆΠ°ΠΉΡΠΈΠ΅ Π³ΠΎΠ΄Ρ ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΡΠ²ΠΎ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ ΡΠ°ΡΡΡΠΈΡΡΠ²Π°ΡΡ Π½Π° ΠΏΡΠ΅ΠΏΠ°ΡΠ°Ρ, ΠΊΠΎΡΠΎΡΡΠΉ ΠΌΠΎΠ³ Π±Ρ Π·Π°ΠΌΠ΅Π½ΠΈΡΡ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΠ¦Π. ΠΠΎΡΡΠΎΠΌΡ ΡΡΠΈΠ»ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»Π΅ΠΉ Π΄ΠΎΠ»ΠΆΠ½Ρ Π±ΡΡΡ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Ρ Π½Π° ΡΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΠ¦Π Ρ ΡΠ΅Π»ΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ Π΅Π΅ Π·Π°ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠ΅ΠΊΡΠ° ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΠΏΠΎΠ±ΠΎΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ
New advances in Raman study of polyvinylchloride structure
In this work we investigated Raman spectra of a number of industrial grades of polyvinylchloride powder and films, prepared from solutions in tetrahydrofuran and acetophenone. The number and spectral characteristics of the Raman lines in the spectral regions of the C-Cl stretching vibrations and in the region of the C-H and CH2 stretching vibrations were evaluated
Π‘ΠΎΠ½ΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ ΠΈ ΠΈΡ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΈ ΡΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π»ΠΈΡ: ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
Π¦ΠΠΠ¬ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―: ΠΡΡΠ²ΠΈΡΡ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΡΠΎΠ½ΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ ΡΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ ΡΒ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ. ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ«: ΠΠ° Π±Π°Π·Π΅ Π€ΠΠΠ£ Β«ΠΠΠΠ¦ ΠΈΠΌ.Β Π.Π.Β ΠΠ»ΠΌΠ°Π·ΠΎΠ²Π°Β» ΡΒ 50Β Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² (ΠΆΠ΅Π½ΡΠΈΠ½Β β 30) ΠΎΡΠ΅Π½ΠΈΠ»ΠΈ ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ΅ (ΡΠΎΠ»ΡΠΈΠ½Ρ) ΠΈΒ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ΅ (ΠΈΠ½Π΄Π΅ΠΊΡ ΡΡΠΎΠ»ΡΠ΅Π½ΠΈΡ ΠΈΒ ΡΠΊΡΠΊΡΡΡΠΈΡ) ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ ΡΒ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ, Π°Β ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ ΡΒ ΠΏΠΎΠΌΠΎΡΡΡ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
. ΠΠΎΡΠ»Π΅ ΡΠ΅Π³ΠΎ ΠΏΡΠΎΠ²Π΅Π»ΠΈ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΡΡ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΡ ΠΈΒ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·. Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π«: Π’ΠΎΠ»ΡΠΈΠ½Ρ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ (ΡΠ»Π΅Π²Π° ΠΈΒ ΡΠΏΡΠ°Π²Π°) ΠΈΒ Π΅Π΅ ΡΠΊΡΠΊΡΡΡΠΈΡ (ΡΠΏΡΠ°Π²Π°) ΡΠ΄Π°Π»ΠΎΡΡ ΠΎΡΠ΅Π½ΠΈΡΡ ΡΒ Π²ΡΠ΅Ρ
ΠΈΡΠΏΡΡΡΠ΅ΠΌΡΡ
; ΡΠΊΡΠΊΡΡΡΠΈΡ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ ΡΠ»Π΅Π²Π°Β β ΡΠΎΠ»ΡΠΊΠΎ ΡΒ 20Β % ΠΈΡΠΏΡΡΡΠ΅ΠΌΡΡ
. Π‘ΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡ Π²ΡΠΏΠΎΠ»Π½ΠΈΠ»ΠΈ ΡΒ Π²ΡΠ΅Ρ
ΠΈΡΠΏΡΡΡΠ΅ΠΌΡΡ
. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΠΎΠ³Π»Π°ΡΡΡΡΡΡ ΡΒ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΠΌΠΈ. ΠΒ ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΡΠ΅ ΠΈΒ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π΄Π»Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π²Β ΡΠ°ΠΌΠΊΠ°Ρ
ΡΠ΅ΡΠ΅ΡΠ΅Π½ΡΠ½ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ. Π‘ΠΈΠ»Π° ΠΈΠ½ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΌΡΡΡ ΡΠ°ΠΊΠΆΠ΅ ΠΎΠΊΠ°Π·Π°Π»Π°ΡΡ ΡΠΎΠΏΠΎΡΡΠ°Π²ΠΈΠΌΠΎΠΉ ΡΒ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ. ΠΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π½Π΅ Π²ΡΡΠ²ΠΈΠ» ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΡ
Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Π΅ΠΉ ΠΌΠ΅ΠΆΠ΄Ρ ΠΈΠ·ΡΡΠ΅Π½Π½ΡΠΌΠΈ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΡΠΌΠΈ ΠΈΒ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠ°ΠΌΠΈ. Π’Π°ΠΊΠΆΠ΅ Π½Π΅ Π±ΡΠ»ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΎ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ ΠΈΒ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΡΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ. ΠΠ°ΠΉΠ΄Π΅Π½Ρ ΡΠ»Π°Π±ΡΠ΅ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ ΠΈΒ Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ°ΠΌΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
: ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π° ΠΈΒ ΠΈΠ½Π΄Π΅ΠΊΡΠΎΠΌ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π°. ΠΠ«ΠΠΠΠ«: Π£Π»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠ°Π±ΠΎΡΡ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ Π½Π΅ ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΡΡ ΠΈΠ»ΠΈ ΠΏΠ»ΠΎΡ
ΠΎ ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΡΡ ΡΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ. Π£Β Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ Π½Π΅Ρ ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΉ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄ΠΈΠ°ΡΡΠ°Π³ΠΌΡ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΎΠ½ΠΎ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅ Π΄Π°Π΅Ρ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΎΒ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ
- β¦